Baker Bros. Advisors LP Closed Holding Positions

Baker Bros. Advisors LP

  • $9.34 Billion
  • Q3 2024
Stock Closed Quarter Shares Sold Price Range Trade History
Neurocrine Biosciences, Inc.
Q4 2020 Filed on Feb 16, 2021
30,770,000
N/A
Urovant Sciences Ltd.
Q4 2020 Filed on Feb 16, 2021
978,505
N/A
APLT
Applied Therapeutics Inc.

Healthcare
Q4 2020 Filed on Feb 16, 2021
38,034
$15.44 - $24.23 $587K - $922K
Immunomedics, Inc.
Q4 2020 Filed on Feb 16, 2021
237,694
N/A
CPRX
Catalyst Pharmaceuticals, Inc.

Healthcare
Q4 2020 Filed on Feb 16, 2021
474,400
$2.97 - $3.83 $1.41M - $1.82M
Sunesis Pharmaceuticals, Inc.
Q4 2020 Filed on Feb 16, 2021
53,066
N/A
MTNB
Matinas Bio Pharma Holdings, Inc.

Healthcare
Q3 2020 Filed on Nov 16, 2020
2,096,375
$0.67 - $0.96 $1.4M - $2.01M
Abeona Therapeutics Inc.
Q3 2020 Filed on Nov 16, 2020
1,590,686
N/A
Arya Sciences Acquisition Corp.
Q3 2020 Filed on Nov 16, 2020
150,000
N/A
Principia Biopharma Inc.
Q3 2020 Filed on Nov 16, 2020
1,580,873
N/A
Seattle Genetics, Inc.
Q3 2020 Filed on Nov 16, 2020
47,269,424
N/A
MRKR
Marker Therapeutics, Inc.

Healthcare
Q3 2020 Filed on Nov 16, 2020
240,505
$1.5 - $2.2 $361K - $529K
Aimmune Therapeutics, Inc.
Q3 2020 Filed on Nov 16, 2020
673,908
N/A
HARP
Harpoon Therapeutics, Inc.

Healthcare
Q2 2020 Filed on Aug 14, 2020
204,467
$11.11 - $24.72 $2.27M - $5.05M
CTMX
Cytom X Therapeutics, Inc.

Healthcare
Q2 2020 Filed on Aug 14, 2020
20,000
$7.4 - $14.64 $148K - $293K
GTHX
G1 Therapeutics, Inc.

Healthcare
Q2 2020 Filed on Aug 14, 2020
88,026
$9.57 - $24.37 $842K - $2.15M
Bio Delivery Sciences International, Inc.
Q2 2020 Filed on Aug 14, 2020
1,638,334
N/A
URGN
Uro Gen Pharma Ltd.

Healthcare
Q2 2020 Filed on Aug 14, 2020
672,912
$16.5 - $29.7 $11.1M - $20M
Ra Pharmaceuticals, Inc.
Q2 2020 Filed on Aug 14, 2020
2,093,839
N/A
Ar Tara Therapeutics, Inc.
Q2 2020 Filed on Aug 14, 2020
199,671
N/A
Millendo Therapeutics, Inc.
Q2 2020 Filed on Aug 14, 2020
833,333
N/A
Minerva Neurosciences, Inc.
Q2 2020 Filed on Aug 14, 2020
688,531
N/A
Bellicum Pharmaceuticals, Inc.
Q1 2020 Filed on May 15, 2020
2,677,818
N/A
Trillium Therapeutics Inc.
Q1 2020 Filed on May 15, 2020
1,100,000
N/A
DVAX
Dynavax Technologies Corp

Healthcare
Q1 2020 Filed on May 15, 2020
75,000
$2.27 - $6.2 $170K - $465K
NXTC
Next Cure, Inc.

Healthcare
Q1 2020 Filed on May 15, 2020
150,000
$32.32 - $58.37 $4.85M - $8.76M
YMAB
Y M Abs Therapeutics, Inc.

Healthcare
Q1 2020 Filed on May 15, 2020
138,514
$14.39 - $35.8 $1.99M - $4.96M
Spring Bank Pharmaceuticals, Inc.
Q1 2020 Filed on May 15, 2020
613,144
N/A
Audentes Therapeutics, Inc.
Q1 2020 Filed on May 15, 2020
804,720
N/A
Sierra Oncology, Inc.
Q4 2019 Filed on Feb 14, 2020
2,000,000
N/A
Ritter Pharmaceuticals, Inc.
Q4 2019 Filed on Feb 14, 2020
279,999
N/A
CYCN
Cyclerion Therapeutics, Inc.

Healthcare
Q4 2019 Filed on Feb 14, 2020
202,581
$1.8 - $13.43 $365K - $2.72M
LJPC
La Jolla Pharmaceutical CO

Healthcare
Q4 2019 Filed on Feb 14, 2020
1,559,231
$2.42 - $8.76 $3.77M - $13.7M
Forty Seven, Inc.
Q4 2019 Filed on Feb 14, 2020
250,000
N/A
Genomic Health, Inc.
Q4 2019 Filed on Feb 14, 2020
9,244,665
N/A
Dermira, Inc.
Q4 2019 Filed on Feb 14, 2020
906,943
N/A
MIST
Milestone Pharmaceuticals Inc.

Healthcare
Q4 2019 Filed on Feb 14, 2020
266,667
$15.4 - $21.9 $4.11M - $5.84M
Spark Therapeutics, Inc.
Q4 2019 Filed on Feb 14, 2020
751,927
N/A
HALO
Halozyme Therapeutics, Inc.

Healthcare
Q4 2019 Filed on Feb 14, 2020
299,969
$14.93 - $19.53 $4.48M - $5.86M
XBIT
X Biotech Inc.

Healthcare
Q4 2019 Filed on Feb 14, 2020
521,327
$8.33 - $19.95 $4.34M - $10.4M
Dova Pharmaceuticals, Inc.
Q4 2019 Filed on Feb 14, 2020
102,205
N/A
Foamix Pharmaceuticals Ltd.
Q4 2019 Filed on Feb 14, 2020
498,189
N/A
Achillion Pharmaceuticals, Inc.
Q4 2019 Filed on Feb 14, 2020
1,095,359
N/A
AQST
Aquestive Therapeutics, Inc.

Healthcare
Q4 2019 Filed on Feb 14, 2020
99,600
$3.06 - $8.78 $305K - $874K
Acorda Therapeutics, Inc.
Q4 2019 Filed on Feb 14, 2020
2,232,589
N/A
ALRNXXXX
Aileron Therapeutics Inc Com
Q3 2019 Filed on Nov 14, 2019
2,040,000
N/A
Array Bio Pharma Inc.
Q3 2019 Filed on Nov 14, 2019
2,848,567
N/A
Aquinox Pharmaceuticals, Inc.
Q3 2019 Filed on Nov 14, 2019
10,934,154
N/A
Contra Fect Corporation
Q2 2019 Filed on Aug 14, 2019
2,914,536
N/A
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email